These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2649622)

  • 1. Serological pattern of hepatitis B virus markers (HBsAg, anti-HBs, IgM anti-HBc and HBV specific DNA polymerase) in leprosy patients.
    Moudgil KD; Irshad M; Gandhi BM; Mishra R
    Indian J Lepr; 1989 Jan; 61(1):54-60. PubMed ID: 2649622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leprosy and hepatitis B virus markers: incidence of HBsAg and HBeAg in Somalian patients.
    Nuti M; Tarabini G; Palermo P; Tarabini GL; Thamer G
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):580-4. PubMed ID: 122628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus infection in lepromatous and tuberculoid patients from Senegal.
    Yvonnet B; Vincelot P; Millan J; Lesage G; Denis F; Languillon J; Mboup S; Coursaget P; Diop Mar I; Chiron JP
    Acta Leprol; 1989; 7(1):63-6. PubMed ID: 2624077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers.
    Elsana S; Shemer-Avni Y; Sikuler E; Sarov B; Naggan L; Bar-Shany S; Gilon E; Yaari A; Orgel M; Frazer GM; Margalith M
    J Hum Virol; 1997; 1(1):52-7. PubMed ID: 10195231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV) serum markers in Greek leprosy patients.
    Papaioannou DJ; Kaklamani EP; Parissis NG; Koumantaki IG; Karalis DT; Trichopoulos DB
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):245-51. PubMed ID: 3722963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
    Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
    Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the response time of anti-HBc IgM in a hepatitis B case load. Diagnostic implications].
    Cremoni L; Buffa D; Sauco F; Bongetta R; Arosio M; d'Amico P
    Boll Ist Sieroter Milan; 1986; 65(5):430-5. PubMed ID: 3828097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
    Ogutu EO; Amayo EO; Okoth F; Lule GN
    East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection.
    Hadziyannis SJ; Hadziyannis AS; Dourakis S; Alexopoulou A; Horsch A; Hess G
    Hepatogastroenterology; 1993 Dec; 40(6):588-92. PubMed ID: 8119645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.
    Haushofer AC; Hauer R; Brunner H; Köller U; Trubert-Exinger D; Halbmayer WM; Koidl C; Kessler HH
    J Clin Virol; 2004 Apr; 29(4):221-3. PubMed ID: 15018848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.